RECRUITING

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Official Title

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

Quick Facts

Study Start:2021-09-09
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05050617

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \>= 18 years of age
  2. * ED diagnosis of acute pulmonary embolism with identification on CT imaging
  1. * Age \<18 years of age
  2. * Inability to provide informed consent
  3. * Incarceration
  4. * Current PE previously diagnosed prior to index ED visit

Contacts and Locations

Study Contact

Brent A Becker, MD
CONTACT
717 851 4819
bbecker2@wellspan.org
Kristen Oliff, BS
CONTACT
717 851 4104
koliff@wellspan.org

Principal Investigator

Brent A Becker, MD
PRINCIPAL_INVESTIGATOR
WellSpan Health

Study Locations (Sites)

Wellspan York Hospital
York, Pennsylvania, 17403
United States

Collaborators and Investigators

Sponsor: WellSpan Health

  • Brent A Becker, MD, PRINCIPAL_INVESTIGATOR, WellSpan Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-09
Study Completion Date2025-03

Study Record Updates

Study Start Date2021-09-09
Study Completion Date2025-03

Terms related to this study

Additional Relevant MeSH Terms

  • Pulmonary Embolism